REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $416 | +41.5% | 10,730 | +17.5% | 0.00% | +100.0% |
| Q1 2024 | $294 | +185.4% | 9,129 | +153.9% | 0.00% | 0.0% |
| Q4 2023 | $103 | -93.6% | 3,595 | -93.8% | 0.00% | -94.4% |
| Q3 2023 | $1,600 | +175.4% | 57,801 | +115.6% | 0.02% | +157.1% |
| Q1 2023 | $581 | +2.5% | 26,811 | +12.6% | 0.01% | 0.0% |
| Q4 2022 | $567 | -99.9% | 23,804 | -0.7% | 0.01% | +16.7% |
| Q3 2022 | $473,000 | -37.2% | 23,969 | -38.0% | 0.01% | -25.0% |
| Q2 2022 | $753,000 | +325.4% | 38,632 | +456.5% | 0.01% | +700.0% |
| Q1 2022 | $177,000 | +50.0% | 6,942 | +48.0% | 0.00% | 0.0% |
| Q4 2021 | $118,000 | -90.7% | 4,691 | -89.8% | 0.00% | -83.3% |
| Q3 2021 | $1,271,000 | +182.4% | 46,205 | +370.9% | 0.01% | +200.0% |
| Q1 2021 | $450,000 | +54.6% | 9,813 | +17.3% | 0.00% | 0.0% |
| Q3 2020 | $291,000 | -60.4% | 8,365 | -64.0% | 0.00% | -66.7% |
| Q2 2020 | $735,000 | +574.3% | 23,266 | +366.8% | 0.01% | +500.0% |
| Q1 2020 | $109,000 | – | 4,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,909,317 | $75,590,000 | 52.65% |
| TRV GP III, LLC | 7,024,031 | $278,081,000 | 23.88% |
| Ponoi II Management, LLC | 685,011 | $27,120,000 | 19.76% |
| TRV GP IV, LLC | 1,419,900 | $56,214,000 | 18.03% |
| Ponoi Management, LLC | 685,011 | $27,120,000 | 15.52% |
| Column Group LLC | 3,580,252 | $141,742,000 | 12.86% |
| BVF INC/IL | 2,768,049 | $109,587,000 | 4.31% |
| Boxer Capital, LLC | 3,309,264 | $131,014,000 | 4.21% |
| Cormorant Asset Management, LP | 2,495,066 | $98,780,000 | 2.35% |
| Casdin Capital, LLC | 1,634,535 | $64,711,000 | 1.92% |